Researchers reported an overall 73% 30-day survival rate in the small study of patients with right ventricular heart failure, according to data Abiomed released during the Transcatheter Cardiovascular Therapeutics conference in Washington D.C.
Harpoon Medical is looking to move from concept to the clinic with the $3.8 million it raised in its Series A funding round in support of its mitral repair devices.
Israeli device maker Keystone Heart raised $14 million in a Series B funding round in support of its TriGaurd implant, designed to help protect the brain during transcatheter valve replacement procedures.
FDA officials issued a formal warning today asking doctors to avoid a certain method for removing uterine tissue out of concern that it may cause stealthy cancers to spread beyond the uterus.
Benvenue Medical secured 510(k) clearance from the FDA, for its Kiva VCF system to treat vertebral compression fractures.
Santa Clara, Calif.-based Benvenue Medical designs and manufactures minimally invasive spinal repair devices. The Kiva VCF is the company’s marquee product, able to treat vertebral compression fractures due to osteoporosis. The device deploys the Kiva coil and Kiva implant.